(MedPage Today) -- A bill to make healthcare facilities' prices more transparent passed the Senate health committee Wednesday by a vote of 21-1, clearing the way for a vote by the full Senate. One hundred million Americans have a combined $220...
Molina’s second quarter was complicated, with stability in Medicaid and outperformance in Medicare Advantage overshadowed by problems in the ACA exchanges. The trend was “unfortunate,” according to the insurer’s CEO.
Dr. Erica Schwartz, President Trump’s pick to lead the Centers for Disease Control and Prevention (CDC), picked up a key endorsement from Senate Health Committee Chair Bill Cassidy (R-La.) Thursday morning, but a scheduled vote on her nomination was postponed. “I’m confident that she knows what she is doing and will stand against those who...
A year after the Environmental Protection Agency stripped grant money from dozens of communities nationwide during Trump’s DEI crackdown, a small Georgia city is struggling to address environmental health concerns.
In a church in rural Missouri, mourners lined up to say goodbye to Lloyd Gilmore, a 44-year-old Black father who died in police custody last month. His death sparked protests in a city with a long history of racial violence, even as the national conversation about police brutality has waned. Six years after worldwide calls for change, what’s happened to the movement?
Hospitals that see improved long-term results in behavioral health patients will be those that prioritize metrics aligned with their care pathways. The post Rethinking How Hospitals Measure Behavioral Health Success appeared first on MedCity News .
Groundbreaking new therapies have exciting potential to treat and cure diseases while minimizing burden on patients; however, they create major clinical, operational and financial implications that must be planned for years in advance. The post Four Ways Health Systems Should Plan for the Next Wave of Breakthrough Therapies appeared first on MedCity News .
A study of Lilly's retatrutide weight loss drug in people with heart disease did not answer a crucial question — whether it reduces cardiovascular risk